Andrea Tan
Stock Analyst at Goldman Sachs
(0.98)
# 3,498
Out of 4,814 analysts
43
Total ratings
35.29%
Success rate
-12.49%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrea Tan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IOVA Iovance Biotherapeutics | Maintains: Buy | $18 → $16 | $3.07 | +421.17% | 6 | Apr 17, 2025 | |
| DAWN Day One Biopharmaceuticals | Maintains: Buy | $39 → $27 | $6.76 | +299.41% | 6 | Mar 25, 2025 | |
| TARS Tarsus Pharmaceuticals | Maintains: Neutral | $36 → $41 | $49.25 | -16.75% | 3 | Nov 15, 2024 | |
| INSM Insmed | Maintains: Buy | $74 → $102 | $72.47 | +40.75% | 9 | Jul 10, 2024 | |
| SGMT Sagimet Biosciences | Maintains: Neutral | $23 → $6 | $2.21 | +171.49% | 5 | Jul 1, 2024 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Neutral | $31 | $11.21 | +176.54% | 1 | Jun 5, 2024 | |
| RLMD Relmada Therapeutics | Downgrades: Sell | $3 → $2 | $0.29 | +598.32% | 3 | Jun 5, 2024 | |
| KOD Kodiak Sciences | Reinstates: Sell | $2 | $2.84 | -29.58% | 1 | Dec 11, 2023 | |
| KRYS Krystal Biotech | Initiates: Buy | $160 | $168.53 | -5.06% | 1 | Nov 20, 2023 | |
| ABCL AbCellera Biologics | Maintains: Buy | $27 → $24 | $2.42 | +893.79% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $10 → $4 | $1.12 | +257.14% | 2 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $178 → $375 | $301.73 | +24.28% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $13 | $4.61 | +182.30% | 1 | Dec 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6 → $4 | $0.65 | +515.38% | 2 | May 24, 2022 |
Iovance Biotherapeutics
Apr 17, 2025
Maintains: Buy
Price Target: $18 → $16
Current: $3.07
Upside: +421.17%
Day One Biopharmaceuticals
Mar 25, 2025
Maintains: Buy
Price Target: $39 → $27
Current: $6.76
Upside: +299.41%
Tarsus Pharmaceuticals
Nov 15, 2024
Maintains: Neutral
Price Target: $36 → $41
Current: $49.25
Upside: -16.75%
Insmed
Jul 10, 2024
Maintains: Buy
Price Target: $74 → $102
Current: $72.47
Upside: +40.75%
Sagimet Biosciences
Jul 1, 2024
Maintains: Neutral
Price Target: $23 → $6
Current: $2.21
Upside: +171.49%
Arrowhead Pharmaceuticals
Jun 5, 2024
Initiates: Neutral
Price Target: $31
Current: $11.21
Upside: +176.54%
Relmada Therapeutics
Jun 5, 2024
Downgrades: Sell
Price Target: $3 → $2
Current: $0.29
Upside: +598.32%
Kodiak Sciences
Dec 11, 2023
Reinstates: Sell
Price Target: $2
Current: $2.84
Upside: -29.58%
Krystal Biotech
Nov 20, 2023
Initiates: Buy
Price Target: $160
Current: $168.53
Upside: -5.06%
AbCellera Biologics
Aug 4, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $2.42
Upside: +893.79%
Jan 9, 2023
Maintains: Sell
Price Target: $10 → $4
Current: $1.12
Upside: +257.14%
Dec 20, 2022
Maintains: Buy
Price Target: $178 → $375
Current: $301.73
Upside: +24.28%
Dec 15, 2022
Initiates: Sell
Price Target: $13
Current: $4.61
Upside: +182.30%
May 24, 2022
Maintains: Neutral
Price Target: $6 → $4
Current: $0.65
Upside: +515.38%